{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15083889", "DateCompleted": {"Year": "2004", "Month": "07", "Day": "06"}, "DateRevised": {"Year": "2017", "Month": "01", "Day": "12"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0392-856X", "JournalIssue": {"Volume": "22", "Issue": "2", "PubDate": {"Year": "2004", "Season": "Mar-Apr"}}, "Title": "Clinical and experimental rheumatology", "ISOAbbreviation": "Clin Exp Rheumatol"}, "ArticleTitle": "Immunomodulatory effects of sucupira (Pterodon pubescens) seed infusion on collagen-induced arthritis.", "Pagination": {"StartPage": "213", "EndPage": "218", "MedlinePgn": "213-8"}, "Abstract": {"AbstractText": ["To evaluate the clinical and immunomodulatory efficacy of seed extracts from sucupira branca (Pterodon pubescens Benth.), a Brazilian anti-inflammatory folk medicine, against collagen II (CII)-induced arthritis (CIA) in mice.", "Mice were divided into 3 groups: 1) normal control mice received a vehicle (ethanol 15% in water); 2) mice with CIA received the vehicle; and 3) mice with CIA received extract from 1 mg sucupira seeds/day. The daily oral treatments started 21 days after the first collagen immunization, ending 4 weeks later. We analyzed the arthritic index, the histopathology of the joints, the serum anti-CII IgG antibody level, and the absolute counts of the CD4+, CD8+, CD4+CD69+ and CD8+CD69+ subsets of inguinal lymph nodes (LN).", "Sucupira treatment strongly reduced the severity of arthritis (p < 0.001). Vehicle-treated CIA mice exhibited invasive synovial pannus and significant articular leukocyte infiltration, features that were reduced or absent in sucupira-treated mice. Mice with CIA exhibited twice the number of CD4+ and CD8+ LN cells found in control mice. Suctupira-treated mice exhibited these subsets in numbers comparable to the latter. A two-thirds decrease in the level of serum anti-CII IgG antibody and a normalization of the CD4+CD69+ LN cell number in treated mice hallmark a negative regulatory effect of sucupira on B- and CD4 T-cell activation, respectively. The CD8+CD69+ cell number remained roughly the same in the 3 groups.", "The clinical and immunomodulatory effects of sucupira on CIA provides a further experimental basis for the popular use of sucupira in chronic inflammatory diseases."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of the State of Rio de Janeiro, Rio de Janeiro, Brazil."}], "Identifier": [], "LastName": "Coelho", "ForeName": "M G P", "Initials": "MG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sabino", "ForeName": "K C C", "Initials": "KC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dalmau", "ForeName": "S R", "Initials": "SR"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Clin Exp Rheumatol", "NlmUniqueID": "8308521", "ISSNLinking": "0392-856X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adjuvants, Immunologic"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antigens, CD"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Adjuvants, Immunologic"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antigens, CD"}, {"QualifierName": ["blood", "drug therapy", "pathology"], "DescriptorName": "Arthritis, Experimental"}, {"QualifierName": [], "DescriptorName": "Cell Count"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Joints"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Lymph Nodes"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred DBA"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Seeds"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "T-Lymphocyte Subsets"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "4", "Day": "16", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "7", "Day": "9", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "4", "Day": "16", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15083889"]}}], "PubmedBookArticle": []}